bexarotene has been researched along with Autoimmune Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chai, D; Lin, J; Lin, X; Liu, J; Ruan, Q; Xie, H; Xu, C; Zeng, J; Zheng, Q | 1 |
| Alvarado, CS; Busam, KJ; Hale, GA; Horwitz, S; Jaffe, ES; Kim, YH; Mehta, N; Myskowski, P; Pulitzer, M; Wayne, AS; Zwerner, J | 1 |
2 other study(ies) available for bexarotene and Autoimmune Diabetes
| Article | Year |
|---|---|
Retinoid X receptor agonists attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes through LKB1-dependent anti-fibrosis effects.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Bexarotene; Cardiomyopathies; Diabetes Mellitus, Type 1; Fibrosis; Humans; Male; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Retinoid X Receptors; Ribosomal Protein S6 Kinases, 70-kDa; Streptozocin | 2020 |
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticarcinogenic Agents; Bexarotene; Child; Child, Preschool; Diabetes Mellitus, Type 1; Disease-Free Survival; Female; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypothyroidism; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Neoplasm Staging; Panniculitis; Skin Neoplasms; Tetrahydronaphthalenes; Treatment Outcome; Young Adult | 2012 |